Michael R. Buchanan

6.9k total citations · 1 hit paper
147 papers, 5.5k citations indexed

About

Michael R. Buchanan is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Michael R. Buchanan has authored 147 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Cardiology and Cardiovascular Medicine, 37 papers in Hematology and 33 papers in Internal Medicine. Recurrent topics in Michael R. Buchanan's work include Antiplatelet Therapy and Cardiovascular Diseases (46 papers), Venous Thromboembolism Diagnosis and Management (33 papers) and Blood Coagulation and Thrombosis Mechanisms (23 papers). Michael R. Buchanan is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (46 papers), Venous Thromboembolism Diagnosis and Management (33 papers) and Blood Coagulation and Thrombosis Mechanisms (23 papers). Michael R. Buchanan collaborates with scholars based in Canada, United States and Spain. Michael R. Buchanan's co-authors include Stephanie J. Brister, J. Hirsh, Frederick A. Ofosu, Subodh Verma, Todd J. Anderson, George Krasopoulos, W. Scott Beattie, Domenico Paparella, Thomas A. Haas and F. William Orr and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Michael R. Buchanan

144 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis

2008 555 citations George Krasopoulos, Stephanie J. Brister et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Buchanan Canada	40	2.4k	1.3k	1.2k	1.2k	879	147	5.5k
Gerald J. Roth United States	35	1.9k 0.8×	1.1k 0.8×	750 0.6×	2.3k 2.0×	1.9k 2.1×	82	8.0k
Marian A. Packham Canada	38	1.7k 0.7×	1.1k 0.9×	432 0.3×	2.2k 1.9×	854 1.0×	122	5.7k
David C. Sane United States	45	2.4k 1.0×	1.4k 1.1×	726 0.6×	783 0.7×	1.1k 1.3×	152	5.9k
M. Johan Broekman United States	44	1.1k 0.5×	636 0.5×	336 0.3×	1.1k 1.0×	1.2k 1.4×	79	5.2k
Alison H. Goodall United Kingdom	47	1.6k 0.7×	753 0.6×	529 0.4×	2.0k 1.7×	1.2k 1.3×	153	6.1k
Vijay V. Kakkar United Kingdom	37	1.4k 0.6×	1.1k 0.8×	1.3k 1.1×	1.3k 1.1×	1.6k 1.8×	193	5.5k
B Boneu France	39	2.3k 1.0×	1.5k 1.1×	2.0k 1.6×	2.0k 1.7×	493 0.6×	217	5.8k
Steven R. Lentz United States	60	1.5k 0.6×	1.6k 1.2×	772 0.6×	3.0k 2.6×	2.3k 2.6×	199	10.6k
Paolo Golino Italy	43	3.9k 1.7×	1.6k 1.2×	705 0.6×	1.1k 1.0×	1.1k 1.2×	265	7.5k
Björn Wiman Sweden	36	1.5k 0.6×	1.1k 0.8×	444 0.4×	2.7k 2.3×	1.4k 1.6×	92	8.0k

Countries citing papers authored by Michael R. Buchanan

Since Specialization

Citations

This map shows the geographic impact of Michael R. Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Buchanan more than expected).

Fields of papers citing papers by Michael R. Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Buchanan. The network helps show where Michael R. Buchanan may publish in the future.

Co-authorship network of co-authors of Michael R. Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Buchanan. A scholar is included among the top collaborators of Michael R. Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Buchanan. Michael R. Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buchanan, Michael R., et al.. (2023). GEOLOGICAL INVESTIGATIONS OF BEDROCK AND SURFICIAL GEOLOGY IN THE SOUTHERN HALF OF THE RAWLEY SPRINGS QUADRANGLE, VIRGINIA. Abstracts with programs - Geological Society of America. 1 indexed citations

Brister, Stephanie J. & Michael R. Buchanan. (2009). Aspirin “resistance” and its impact on cardiovascular morbidity and mortality: it is real, clinically relevant and should be measured. Heart. 95(15). 1223–1224. 5 indexed citations

Pullman, Gerald S. & Michael R. Buchanan. (2008). Identification and quantitative analysis of stage-specific carbohydrates in loblolly pine (Pinus taeda) zygotic embryo and female gametophyte tissues. Tree Physiology. 28(7). 985–996. 31 indexed citations

Krasopoulos, George, Stephanie J. Brister, W. Scott Beattie, & Michael R. Buchanan. (2008). Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 336(7637). 195–198. 555 indexed citations breakdown →

Paparella, Domenico, Stephanie J. Brister, & Michael R. Buchanan. (2004). Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Medicine. 30(10). 1873–1881. 268 indexed citations

Buchanan, Michael R.. (1999). Linoleic Acid Metabolites in Health and Disease. Advances in experimental medicine and biology. 469. 463–469. 8 indexed citations

Buchanan, Michael R., Peter Horsewood, & Stephanie J. Brister. (1998). Regulation of endothelial cell and platelet receptor-ligand binding by the 12- and 15-lipoxygenase monohydroxides, 12-, 15-HETE and 13-HODE. Prostaglandins Leukotrienes and Essential Fatty Acids. 58(5). 339–346. 32 indexed citations

Cortelazzo, Sergio, Marina Marchetti, Elisabetta Orlando, et al.. (1998). Aspirin increases the bleeding side effects in essential thrombocythemia independent of the cyclooxygenase pathway: Role of the lipoxygenase pathway. American Journal of Hematology. 57(4). 277–282. 26 indexed citations

Buchanan, Michael R., et al.. (1996). Plant alkaloids, tetrandrine and hernandezine, inhibit calcium-depletion stimulated calcium entry in human and bovine endothelial cells. Life Sciences. 58(25). 2327–2335. 22 indexed citations

10.

Lafrenie, Robert M., Michael R. Buchanan, & F. William Orr. (1993). Adhesion molecules and their role in cancer metastasis. Cell Biophysics. 23(1-3). 3–89. 40 indexed citations

11.

Bastida, E, et al.. (1990). Regulation of tumor cell adhesion by intracellular 13-HODE: 15-HETE ratio.. PubMed. 2(5). 281–93. 12 indexed citations

12.

Haas, Thomas A., et al.. (1990). Cyclic AMP regulation of endothelial cell triacylglycerol turnover, 13-hydroxyoctadecadienoic acid (13-HODE) synthesis and endothelial cell thrombogenecity. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1051(2). 174–178. 29 indexed citations

13.

Lauri, D, et al.. (1990). Interleukin-1 increases tumor cell adhesion to endothelial cells through an RGD dependent mechanism: in vitro and in vivo studies. Clinical & Experimental Metastasis. 8(1). 27–32. 53 indexed citations

14.

Ofosu, Frederick A., et al.. (1989). Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan Sulfatea. Annals of the New York Academy of Sciences. 556(1). 123–131. 20 indexed citations

15.

Ofosu, Frederick A., et al.. (1989). Effects of Dermatan Sulfate and Heparin on Inhibition of Thrombus Growth in Vivo. Annals of the New York Academy of Sciences. 556(1). 304–312. 32 indexed citations

16.

Matzner, Yaacov, Martin A. Cohn, Esti Hyam, et al.. (1988). Generation of lipid neutrophil chemoattractant by irradiated bovine aortic endothelial cells.. The Journal of Immunology. 140(8). 2681–2685. 21 indexed citations

17.

Haas, Thomas A., et al.. (1988). Binding of 13-HODE and 5-, 12- and 15-HETE to endothelial cells and subsequent platelet, neutrophil and tumor cell adhesion. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 961(2). 153–159. 36 indexed citations

18.

Haas, Thomas A. & Michael R. Buchanan. (1988). Automated high-performance liquid chromatographic extraction and quantification procedure for lipoxygenase metabolites. Journal of Chromatography B Biomedical Sciences and Applications. 430(1). 1–9. 13 indexed citations

19.

Ofosu, Frederick A., G J Modi, M.A. Blajchman, Michael R. Buchanan, & Edward A. Johnson. (1987). Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate. Biochemical Journal. 248(3). 889–896. 55 indexed citations

20.

Meuleman, D.G., Michael R. Buchanan, Alan R. Giles, & J. Hirsh. (1977). Normalization of Platelet Survival in an Experimental Model after Platelet Exposure of Thrombin in Vitro or adp in Vivo. Thrombosis and Haemostasis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact